Sunhawk Vision Biotech, Inc.

NT$49.95As of Sun 8 Nov 2026, 12:00 UTC
TPEx:7759Healthcare
Country Taiwan
PE (Fwd) •••
TSR 10Y CAGR —
Div yield —
ROE (27.29%)
Biotechnology
Beta (5Y) —
PE TTM —
TSR TTM (27.19%)
Mkt cap NT$3.514B
ROIC (19.21%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
NT$50
0.67%
(27.05%)
Hold 0|2|4|6|10
4Q25
1Q26
2Q26
3Q26
Earnings per shareNT$
0.93
1.00
1.02
1.11
2.98%
15.54%
16.52%
21.35%
RevenueNT$M
293.8
295.4
306.6
316.1
(0.03%)
(1.34%)
0.87%
6.85%
Peers (US$106.1M)
Cap (US$)
PE
102.2M
10.25x
Capital
TTM
5Y
10Y
Leveragex
0.631
0.188
0.109
EBIT/Intx
0.715
1.383
1.486
Own earn%
(11.79)
(10.96)
(11.40)
Sh yield%
14.38
21.20
20.48
Owners
Insiders/Inst%
10.77
63.73
Short interest%
2.99
SBC / revenue%
3.33
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
16
Op margin range%
12–18
$1 testx
—
Incr. ROIC%
5